{"id":"https://openalex.org/W3213675102","doi":"https://doi.org/10.1182/blood-2021-150626","title":"Improved Clinical Outcome of Patients with Myelodysplastic Syndrome (MDS) Progressing after Hypomethylating Agent: In the Era of Novel Therapies","display_name":"Improved Clinical Outcome of Patients with Myelodysplastic Syndrome (MDS) Progressing after Hypomethylating Agent: In the Era of Novel Therapies","publication_year":2021,"publication_date":"2021-11-05","ids":{"openalex":"https://openalex.org/W3213675102","doi":"https://doi.org/10.1182/blood-2021-150626","mag":"3213675102"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2021-150626","doi":"https://doi.org/10.1182/blood-2021-150626","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2021-150626","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004970562","display_name":"Ahmad Ghorab","orcid":"https://orcid.org/0000-0003-3429-2737","observed_orcids":["https://orcid.org/0000-0003-3429-2737"]},"institutions":[{"id":"https://openalex.org/I4210146710","display_name":"Mayo Clinic in Florida","ror":"https://ror.org/03zzw1w08","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210146710"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ahmad Ghorab","raw_affiliation_strings":["Hematology and Oncology, Mayo Clinic, Jacksonville, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology and Oncology, Mayo Clinic, Jacksonville, FL","institution_ids":["https://openalex.org/I4210146710"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008422091","display_name":"Aref Al\u2010Kali","orcid":"https://orcid.org/0000-0002-0824-3715","observed_orcids":["https://orcid.org/0000-0002-0824-3715"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aref Al-Kali","raw_affiliation_strings":["Division of Hematology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112576666","display_name":"Michelle A. Elliot","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michelle A. Elliot","raw_affiliation_strings":["Division of Hematology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020872528","display_name":"Mithun Vinod Shah","orcid":"https://orcid.org/0000-0002-5359-336X","observed_orcids":["https://orcid.org/0000-0002-5359-336X"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mithun V. Shah","raw_affiliation_strings":["Division of Hematology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057941081","display_name":"Jeanne M. Palmer","orcid":"https://orcid.org/0000-0002-2185-1504","observed_orcids":["https://orcid.org/0000-0002-2185-1504"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I4210127938","display_name":"Mayo Clinic Hospital","ror":"https://ror.org/03660jn93","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099","https://openalex.org/I4210127938"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeanne M. Palmer","raw_affiliation_strings":["Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4210127938"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023628069","display_name":"Hemant S. Murthy","orcid":"https://orcid.org/0000-0003-4534-4248","observed_orcids":["https://orcid.org/0000-0003-4534-4248"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I4210146710","display_name":"Mayo Clinic in Florida","ror":"https://ror.org/03zzw1w08","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210146710"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hemant S. Murthy","raw_affiliation_strings":["Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4210146710"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017327825","display_name":"Mohamed A. Kharfan\u2010Dabaja","orcid":"https://orcid.org/0000-0001-7394-5185","observed_orcids":["https://orcid.org/0000-0001-7394-5185"]},"institutions":[{"id":"https://openalex.org/I4210146710","display_name":"Mayo Clinic in Florida","ror":"https://ror.org/03zzw1w08","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210146710"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mohamed A. Kharfan-Dabaja","raw_affiliation_strings":["Mayo Clinic, Jacksonville, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Jacksonville, FL","institution_ids":["https://openalex.org/I4210146710"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085360755","display_name":"Mark Robert Litzow","orcid":"https://orcid.org/0000-0002-9816-6302","observed_orcids":["https://orcid.org/0000-0002-9816-6302"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark R. Litzow","raw_affiliation_strings":["Division of Hematology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035051206","display_name":"James M. Foran","orcid":"https://orcid.org/0000-0003-1673-1708","observed_orcids":["https://orcid.org/0000-0003-1673-1708"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I4210146710","display_name":"Mayo Clinic in Florida","ror":"https://ror.org/03zzw1w08","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210146710"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James M. Foran","raw_affiliation_strings":["Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4210146710"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5079157559","display_name":"Talha Badar","orcid":"https://orcid.org/0000-0003-1548-918X","observed_orcids":["https://orcid.org/0000-0003-1548-918X"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I4210146710","display_name":"Mayo Clinic in Florida","ror":"https://ror.org/03zzw1w08","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210146710"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Talha Badar","raw_affiliation_strings":["Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4210146710"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"138","issue":"Supplement 1","first_page":"3688","last_page":"3688"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/myelodysplastic-syndrome","display_name":"myelodysplastic syndrome","score":0.9950000047683716},{"id":"https://openalex.org/keywords/hypomethylating-agent-resistance","display_name":"hypomethylating agent resistance","score":0.8159999847412109},{"id":"https://openalex.org/keywords/azacitidine","display_name":"azacitidine","score":0.8870000243186951},{"id":"https://openalex.org/keywords/decitabine","display_name":"decitabine","score":1.0},{"id":"https://openalex.org/keywords/venetoclax","display_name":"venetoclax","score":0.9679999947547913},{"id":"https://openalex.org/keywords/cpx-351","display_name":"CPX-351","score":0.8560000061988831},{"id":"https://openalex.org/keywords/relapsed-acute-myeloid-leukemia","display_name":"relapsed acute myeloid leukemia","score":0.7900000214576721},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.6159999966621399},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.7089999914169312},{"id":"https://openalex.org/keywords/tp53-mutation","display_name":"TP53 mutation","score":0.7599999904632568},{"id":"https://openalex.org/keywords/splicing-mutation","display_name":"splicing mutation","score":0.5920000076293945},{"id":"https://openalex.org/keywords/asxl1","display_name":"ASXL1","score":0.7059999704360962},{"id":"https://openalex.org/keywords/runx1","display_name":"RUNX1","score":0.609000027179718},{"id":"https://openalex.org/keywords/dnmt3a","display_name":"DNMT3A","score":0.8920000195503235},{"id":"https://openalex.org/keywords/idh-mutation","display_name":"IDH mutation","score":0.46399998664855957}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8219680786132812},{"id":"https://openalex.org/C2780235182","wikidata":"https://www.wikidata.org/wiki/Q1181878","display_name":"Decitabine","level":5,"score":0.8160665035247803},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7533789873123169},{"id":"https://openalex.org/C2776012956","wikidata":"https://www.wikidata.org/wiki/Q17125294","display_name":"Hypomethylating agent","level":5,"score":0.7446886301040649},{"id":"https://openalex.org/C2776239401","wikidata":"https://www.wikidata.org/wiki/Q416451","display_name":"Azacitidine","level":5,"score":0.6177146434783936},{"id":"https://openalex.org/C2780817109","wikidata":"https://www.wikidata.org/wiki/Q954625","display_name":"Myelodysplastic syndromes","level":3,"score":0.5859352350234985},{"id":"https://openalex.org/C2780240888","wikidata":"https://www.wikidata.org/wiki/Q6052586","display_name":"International Prognostic Scoring System","level":4,"score":0.5580920577049255},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4987316131591797},{"id":"https://openalex.org/C2779675984","wikidata":"https://www.wikidata.org/wiki/Q23671272","display_name":"Venetoclax","level":4,"score":0.47453105449676514},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.30635619163513184},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.17402857542037964},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.08905115723609924},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C190727270","wikidata":"https://www.wikidata.org/wiki/Q874745","display_name":"DNA methylation","level":4,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2021-150626","doi":"https://doi.org/10.1182/blood-2021-150626","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2021-150626","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4296468421","https://openalex.org/W4283381927","https://openalex.org/W2548196460","https://openalex.org/W2984459449","https://openalex.org/W4296468446","https://openalex.org/W4405039020","https://openalex.org/W4283322270","https://openalex.org/W4417010217","https://openalex.org/W4389233394","https://openalex.org/W4417013404"],"abstract_inverted_index":{"Abstract":[0],"Introduction:":[1],"Historically,":[2],"clinical":[3,60,76,95,120],"outcome":[4,61,77,96,497,518,558],"of":[5,27,40,66,78,88,97,122,133,147,180,194,214,267,269,281,331,361,366,463,488,498,511,519,559,562,702],"patients":[6,68,80,100,182,195,215,248,282,315,320,332,355,500,522,534,551],"with":[7,22,53,335,442,535,547],"myelodysplastic":[8],"syndrome":[9],"(MDS),":[10],"progressing":[11,81,128,501],"on":[12,82,103,129,167,444,502,698],"hypomethylating":[13],"agents":[14],"(HMA;":[15],"azacitidine":[16,251],"or":[17,58,152,231,242,704],"decitabine)":[18],"has":[19,62],"been":[20],"dismal":[21],"median":[23,178,261,364,388],"overall":[24],"survival":[25],"(OS)":[26],"less":[28],"than":[29],"6":[30],"months":[31,274,395],"(Jabbour":[32],"et":[33],"al.":[34],"Cancer":[35],"2010).":[36],"With":[37],"recent":[38,506],"approval":[39],"venetoclax":[41,258,334,528],"based":[42],"combinations":[43],"for":[44,51,163,405,433,474],"acute":[45],"myeloid":[46],"leukemia":[47],"(AML)":[48],"and":[49,106,115,143,207,240,255,305,322,339,349,418,544],"CPX-351":[50,302,443],"AML":[52,285,445],"MDS":[54,79,99,499,537],"related":[55],"changes":[56],"(primary":[57],"secondary),":[59],"improved":[63,517],"in":[64,84,175,191,358,458,504,533,541,549],"sub-set":[65],"high-risk":[67,521,536,563],"compared":[69,523],"to":[70,263,284,524,554,575],"historical":[71,525],"cohorts.":[72],"Hence,":[73],"we":[74],"analyzed":[75,94],"HMA,":[83,336],"the":[85,109,181,402,486,493,505,509],"current":[86],"era":[87],"novel":[89],"therapies.":[90],"Methods:":[91],"We":[92,118,156],"retrospectively":[93],"43":[98],"who":[101],"progressed":[102,283,321],"HMA-based":[104,130,141,168,246,270,287],"therapy":[105,139,142,247,271,343,372,425,449,469,546],"treated":[107],"at":[108,382,411],"Mayo":[110],"Clinic":[111],"between":[112],"February":[113,116],"2015":[114],"2021.":[117],"describe":[119],"characteristics":[121,172],"these":[123,520],"patients,":[124],"therapies":[125,295],"received":[126,249,333,356],"after":[127,136,165,286,368,390,407,421,465],"therapy,":[131],"duration":[132,365],"response":[134,367],"attained":[135],"1st":[137],"line":[138,294,342,371,424,468],"post":[140,296,344,373,426,470],"OS":[144,164,389,406,476],"from":[145,265],"time":[146,262,266,413],"HMA":[148,256,297,345,374,391,408,427,471,503,530],"failure":[149,392],"till":[150],"death":[151],"last":[153],"follow":[154],"up.":[155],"also":[157],"performed":[158],"Cox":[159],"regression":[160],"multivariate":[161,459],"analysis":[162,404],"progression":[166,264,380,446],"therapy.":[169,288],"Results:":[170],"Baseline":[171],"are":[173],"summarized":[174],"Table":[176],"1.The":[177],"age":[179],"were":[183,225,250,346],"69":[184],"years":[185],"(range":[186],"[R],":[187],"48-93).":[188],"R-IPSS":[189,436],"score":[190],"this":[192,359,491,560],"cohort":[193,360],"was":[196,272,298,375,393],"very":[197,208],"low":[198,200],"(2[5%]),":[199],"(5[12%]),":[201],"intermediate":[202],"(5":[203],"[12%]),":[204],"high":[205,209,438],"(11[26%])":[206],"(20":[210],"[46.5%]).":[211],"Forty-nine":[212],"percent":[213,278],"had":[216,326],"complex":[217],"cytogenetics.":[218],"Most":[219],"commonly":[220],"occurring":[221],"mutations":[222],"(\u2265":[223],"5%)":[224],"TP53":[226],"(42%),":[227],"splicing":[228],"mutation":[229],"(SRSF2/SF3B1/":[230],"U2AF1)":[232],"(16%),":[233],"ASXL1":[234],"(12%),":[235],"RUNX1":[236],"(7%),":[237],"DNMT3A":[238],"(5%)":[239],"IDH1/":[241],"IDH2":[243],"(5%).":[244],"The":[245,260,289,329,363,387],"(40%),":[252],"decitabine":[253],"(30%)":[254],"plus":[257,529],"(30%).":[259],"initiation":[268],"5":[273],"(R=":[275],"1-30).":[276],"Sixty-three":[277],"(n=":[279],"27)":[280],"most":[290],"common":[291],"1":[292,323,337,369,383,422,466,566],"st":[293,338,370,423,467],"venetoclax-based":[299,448],"(12":[300,303],"[28%]),":[301,304],"allogeneic":[306],"stem":[307],"cell":[308],"transplantation":[309],"(SCT)":[310],"(4":[311],"[9%]).":[312],"Fifteen":[313],"(45.5%)":[314],"achieved":[316],"CR/CRi,":[317],"17":[318],"(51.5%)":[319],"(3%)":[324],"patient":[325],"stable":[327],"disease.":[328],"percentage":[330],"2":[340],"nd":[341],"26%,":[347],"28%":[348],"10%,":[350],"respectively.":[351],"Overall,":[352],"11":[353],"(25%)":[354],"SCT":[357,410,548],"patients.":[362,564],"not":[376,453],"reached":[377],"(NR;":[378],"66%":[379],"free":[381],"year)":[384],"(Figure":[385,399],"1A).":[386],"12.7":[394],"(95%":[396],"CI:":[397,480],"3.1-22.2)":[398],"1B).":[400],"In":[401],"univariate":[403],"failure,":[409],"any":[412],"point":[414],"(p":[415],"=":[416],"0.01)":[417],"achieving":[419],"CR/CRi":[420,464],"(p=":[428,439,450],"<0.001)":[429],"showed":[430],"favorable":[431,475],"significance":[432,473],"OS.":[434],"Whereas,":[435],"high/very":[437],"0.35),":[440],"treatment":[441],"(p=0.33),":[447],"0.59)":[451],"did":[452],"show":[454],"statistical":[455],"significance.":[456],"Subsequently,":[457],"analysis,":[460,513],"only":[461],"achievement":[462],"retained":[472],"(HR:":[477],"0.19,":[478],"95%":[479],"0.04-0.86,":[481],"p=":[482],"0.03).":[483],"Conclusions:":[484],"To":[485],"best":[487],"our":[489,514],"knowledge,":[490],"is":[492],"first":[494],"report":[495,515],"analyzing":[496],"era.":[507],"Acknowledging":[508],"limitations":[510],"retrospective":[512],"suggests":[516],"data.":[526],"Utilizing":[527],"combination":[531],"earlier":[532],"as":[538],"being":[539],"evaluated":[540],"VERONA":[542],"trial":[543],"consolidation":[545],"eligible":[550],"have":[552],"potential":[553],"improve":[555],"long":[556],"term":[557],"group":[561],"Figure":[565,567],"1.":[568],"Disclosures":[569],"Al-Kali:":[570],"Astex:":[571],"Other:":[572,617,621,631],"Research":[573,578,582,585,589,594,599,604,608,611,614,625,628,639,642,646,663,674,677,680,683,686,689,692],"support":[574],"institution;":[576],"Novartis:":[577],"Funding.":[579,600,605,693],"Palmer:":[580],"PharmaEssentia:":[581],"Funding;":[583,586,590,595,609,612,615,626,629,640,643,647,664,675,678,681,684,687,690],"Incyte:":[584],"Protagonist:":[587],"Consultancy,":[588,593,598],"CTI":[591],"BioPharma:":[592],"Sierra":[596],"Oncology:":[597],"Murthy:":[601],"CRISPR":[602],"Therapeutics:":[603],"Litzow:":[606],"Pluristem:":[607],"Actinium:":[610],"AbbVie:":[613],"Omeros:":[616],"Advisory":[618,622],"Board;":[619,623],"Jazz:":[620],"Amgen:":[624],"Astellas:":[627],"Biosight:":[630],"Data":[632],"monitoring":[633],"committee.":[634],"Foran:":[635],"pfizer:":[636],"Honoraria;":[637,649,652,655,657,659,661,666,668,670,672],"takeda:":[638],"trillium:":[641],"boehringer":[644],"ingelheim:":[645],"syros:":[648],"sanofi":[650],"aventis:":[651],"revolution":[653],"medicine:":[654],"servier:":[656],"bms:":[658],"certara:":[660],"abbvie:":[662],"OncLive:":[665],"gamida:":[667],"taiho:":[669],"novartis:":[671],"aptose:":[673],"actinium:":[676],"kura:":[679],"h3bioscience:":[682],"aprea:":[685],"sellas:":[688],"stemline:":[691],"Badar:":[694],"Pfizer":[695],"Hematology-Oncology:":[696],"Membership":[697],"an":[699],"entity's":[700],"Board":[701],"Directors":[703],"advisory":[705],"committees.":[706]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2021-11-22T00:00:00"}